Bioavailability determination of two crystal forms of sulfameter in humans from urinary excretion data.

Abstract Urinary excretion data were used to deter mine the bioavailability of crystal Forms II and III of sulfameter in humans. Agreement was observed between the ratio of absorption parameters of the two forms deter mined in the present study and those previously obtained from blood level data. Although the urine data revealed a significant difference in the rate of absorption of the two forms, no significant difference was observed in the extent of absorption of both forms as indicated by the 72-hr urinary excretion data. Urinary excretion rates during the absorption phase, without further mathematical treatment, were statistically shown to be adequate means for comparing the bioavailability of sulfameter crystal forms. The use of urinary excretion data of sulfameter as an alternative to the use of blood level data is discussed.

[1]  E. McChesney,et al.  Pharmacokinetic model for nalidixic acid in man. II. Parameters for absorption, metabolism, and elimination. , 1966, Journal of pharmaceutical sciences.

[2]  I. McGilveray,et al.  Comparison of bioavailabilities and dissolution characteristics of commercial tablet formulations of sulfamethizole. , 1972, Journal of pharmaceutical sciences.

[3]  M. Gibaldi,et al.  Calculation of absorption rate constants for drugs with incomplete availability. , 1973, Journal of Pharmacy and Science.

[4]  S. Khalil,et al.  Sulphamethoxydiazine crystal forms , 1971, The Journal of pharmacy and pharmacology.

[5]  M. Lewis,et al.  Pharmacokinetic profile of sulfisoxazole following intravenous, intramuscular, and oral administration to man. , 1972, Journal of pharmaceutical sciences.

[6]  S. Khalil,et al.  Effect of additives on the kinetics of interconversion of sulphamethoxydiazine crystal forms , 1973, The Journal of pharmacy and pharmacology.

[7]  J. Wagner,et al.  KINETIC ANALYSIS OF BLOOD LEVELS AND URINARY EXCRETION IN THE ABSORPTIVE PHASE AFTER SINGLE DOSES OF DRUG. , 1964, Journal of pharmaceutical sciences.

[8]  A. Glazko,et al.  Physical factors affecting the rate of absorption of chloramphenicol esters. , 1958, Antibiotics & chemotherapy.

[9]  W. H. Barr,et al.  Assessment of the biologic availability of tetracycline products in man , 1972, Clinical pharmacology and therapeutics.

[10]  J. Wagner,et al.  Direct Proportionality of Urinary Excretion Rate and Serum Level of Tetracycline in Human Subjects , 1963, Nature.

[11]  B. Rodda,et al.  Physiological disposition of fenoprofen in man. II. Plasma and urine pharmacokinetics after oral and intravenous administration. , 1972, Journal of pharmaceutical sciences.

[12]  John G. Wagner,et al.  Biopharmaceutics and Relevant Pharmacokinetics , 1971 .

[13]  S. Khalil,et al.  GI absorption of two crystal forms of sulfameter in man. , 1972, Journal of pharmaceutical sciences.

[14]  M. Chaplin,et al.  Absorption, distribution, metabolism, and excretion of naproxen in various laboratory animals and human subjects. , 1972, Journal of pharmaceutical sciences.

[15]  B. Rodda,et al.  Physiological disposition of fenoprofen in man. I. Pharmacokinetic comparison of calcium and sodium salts administered orally. , 1971, Journal of pharmaceutical sciences.

[16]  A. C. Bratton,et al.  A NEW COUPLING COMPONENT FOR SULFANILAMIDE DETERMINATION , 1939 .

[17]  S. Riegelman,et al.  New method for calculating the intrinsic absorption rate of drugs. , 1968, Journal of pharmaceutical sciences.